BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15131262)

  • 1. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.
    Ishii S; Yamada M; Satoh T; Monden T; Hashimoto K; Shibusawa N; Onigata K; Morikawa A; Mori M
    Mol Endocrinol; 2004 Jul; 18(7):1708-20. PubMed ID: 15131262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor.
    Umezawa R; Yamada M; Horiguchi K; Ishii S; Hashimoto K; Okada S; Satoh T; Mori M
    Endocrinology; 2009 Jul; 150(7):3425-32. PubMed ID: 19299458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
    Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
    Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
    Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
    J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression.
    Gloss B; Giannocco G; Swanson EA; Moriscot AS; Chiellini G; Scanlan T; Baxter JD; Dillmann WH
    Endocrinology; 2005 Nov; 146(11):4926-33. PubMed ID: 16081636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation.
    Clifton-Bligh RJ; de Zegher F; Wagner RL; Collingwood TN; Francois I; Van Helvoirt M; Fletterick RJ; Chatterjee VK
    Mol Endocrinol; 1998 May; 12(5):609-21. PubMed ID: 9605924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
    Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
    Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo repression of an erythroid-specific gene by distinct corepressor complexes.
    Rietveld LE; Caldenhoven E; Stunnenberg HG
    EMBO J; 2002 Mar; 21(6):1389-97. PubMed ID: 11889044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
    Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
    J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor.
    Tagami T; Park Y; Jameson JL
    J Biol Chem; 1999 Aug; 274(32):22345-53. PubMed ID: 10428804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CCAAT/enhancer-binding protein, histone acetylation, and coactivator recruitment in the regulation of malic enzyme transcription by thyroid hormone.
    Yin L; Wang Y; Dridi S; Vinson C; Hillgartner FB
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):43-52. PubMed ID: 16293364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor.
    Alenghat T; Yu J; Lazar MA
    EMBO J; 2006 Sep; 25(17):3966-74. PubMed ID: 16917504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.
    Satoh T; Monden T; Ishizuka T; Mitsuhashi T; Yamada M; Mori M
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):137-49. PubMed ID: 10509808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback on hypothalamic TRH transcription is dependent on thyroid hormone receptor N terminus.
    Guissouma H; Dupré SM; Becker N; Jeannin E; Seugnet I; Desvergne B; Demeneix BA
    Mol Endocrinol; 2002 Jul; 16(7):1652-66. PubMed ID: 12089358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter.
    Kim SW; Ho SC; Hong SJ; Kim KM; So EC; Christoffolete M; Harney JW
    J Biol Chem; 2005 Apr; 280(15):14545-55. PubMed ID: 15701601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feed-forward repression mechanism anchors the Sin3/histone deacetylase and N-CoR/SMRT corepressors on chromatin.
    Vermeulen M; Walter W; Le Guezennec X; Kim J; Edayathumangalam RS; Lasonder E; Luger K; Roeder RG; Logie C; Berger SL; Stunnenberg HG
    Mol Cell Biol; 2006 Jul; 26(14):5226-36. PubMed ID: 16809761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.
    Evert BO; Araujo J; Vieira-Saecker AM; de Vos RA; Harendza S; Klockgether T; Wüllner U
    J Neurosci; 2006 Nov; 26(44):11474-86. PubMed ID: 17079677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.